Yu X. et al. (2011) Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer, 11:96.
Malerba S. et al. (2013) A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular disease. Eur J Epidemiol, 28(7):522-539.
Je Y. and Giovannucci E. (2013) Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies. Brit J Nutr, 111(7):1162-1173.
Crippa A. et al. (2014) Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: A dose-response meta-analysis. Am J Epidemiol, 180(8):763-775.
Wierzejska R. (2015) Coffee consumption vs cancer risk – A review of scientific data. Rocz Pantsw Zakl Hig, 66(4):293-298.
Tamakoshi A. et al. (2011) Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol, 26(4):285-293.
EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA) (2015) Scientific Opinion on the safety of caffeine. EFSA Journal, 13(5):4102.
Islami F. et al. (2009) High-temperature beverages and foods and esophageal cancer risk-A systematic review. Int J Cancer, 125:491-524.
Tverdal A. et al. (2011) Coffee intake and oral-oesophageal cancer: follow-up of 389,624 Norwegian men and women 40 – 45 years. British Journal of Cancer, 105(1):157–161.
Zheng J.S. et al. (2013) Effects of Green Tea, Black Tea, and Coffee Consumption on the Risk of Esophageal Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Nutrition and Cancer, 65(1):1-16.
World Cancer Research Fund/American Institute for Cancer Research (2007) Second Expert Report: Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, D.C., AICR.
Botelho F. et al. (2006) Coffee and gastric cancer: systematic review and meta-analysis. Cad Saude Publica, 22:889–900.
Xie F. et al. (2014) Coffee consumption and risk of gastric cancer: a large updated meta-analysis of prospective studies. Nutrients, 18:6(9):3734-46.
Li L. et al. (2015) Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies. BMC Cancer, 15:733.
Liu H. et al. (2015) Effect of Coffee Consumption on the Risk of Gastric Cancer: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. PLoS One, 10(5):e0128501.
Zeng S.B. et al. (2015) Long term coffee consumption and risk of gastric cancer. Medicine, 94(38).
Shen Z. et al. (2015) Coffee consumption and risk of gastric cancer: an updated meta-analysis. Clinics and Research in Hepatology and Gastroenterology, 39(2):245-53.
Deng W. et al. (2015) Coffee consumption and risk of incident gastric cancer: a meta-analysis of prospective cohort studies. Nutr & Cancer, published online ahead of print.
Turati F. et al. (2010) Coffee and cancers of the upper digestive and respiratory tracts: meta-analyses of observational studies. Ann Oncol, 22(3):536-544.
Zhang Y. et al. (2015) Association between coffee consumption and the risk of oral cancer: a meta-analysis of observational studies. Int J Exp Med, 8(7):11657-11665.
Ouyang Z. (2014) Association between coffee consumption and risk of laryngeal cancer: a meta-analysis. Int J Clin Exp Med, 7(2):5192–5200.
Chen J. and Long S. (2014) Tea and coffee consumption and risk of laryngeal cancer: A systematic review meta-analysis. PLoS One, 9(12):e112006.
Larsson S.C., Wolk A. (2007) Coffee consumption and risk of Liver Cancer: A meta-analysis. Gastroenterol, 132:1740-1745.
Bravi F. et al. (2007) Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology, 46:430-5.
Sang L.X. (2013) Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol, 13:34.
Bravi F. et al. (2013) Coffee reduces the risk for hepatocellular carcinoma: An updated meta-analysis. Clin Gastro and Hepatol, 11:1413-1421.
Bamia C. et al. (2015) Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study. Int J Cancer, 136(8):1899-908.
Leung W.W. et al. (2011) Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study. J Epidemiol Community Health, 65:556-558.
Freedman N.D. et al. (2009) Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology, 50:1360-9.
Aleksandrova K. et al. (2015) The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr, 102(6):1498-508.
Kang N.J. et al. (2011) Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis, 32(6):921-928.
Sala M. et al. (2000) Coffee consumption and bladder cancer in non-smokers: a pooled analysis of case-control studies in European Countries. Cancer Causes and Control, 11: 925-931.
Zeegers M.P.A. et al. (2001) Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis. Int J Epidemiol, 30:353-362.
Pelucchi C. and La Vecchia C. (2009) Alcohol, coffee and bladder cancer risk: a systematic review of epidemiological studies. Eur J Cancer Prev, 18:62-68.
Zhou Y. et al. (2012) A dose response meta-analysis of coffee consumption and bladder cancer. Prev Med, 51(1):14-22.
Huang T.B. et al. (2014) Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies. Int Urol Nephrol, 46(8):1481-93.
Bai Y. et al. (2014) Relationship between bladder cancer and total fluid intake: a meta-analysis of epidemiological evidence. World J Surgical Oncology, 12:223.
Wu W. et al. (2015) Coffee consumption and bladder cancer: a meta-analysis of observational studies. Sci Reports, 5:9051.
Sugiyama K. et al. (2016) The association between coffee consumption and bladder cancer incidence in a pooled analysis of the Miyagi cohort study and the Ohsaki cohort study. Eur J Canc Prev, published online ahead of print.
Pelucchi C. et al. (2008) Coffee and alcohol consumption and bladder cancer. Scand J Urol Nephrol, 42 (Suppl 218):37-44.
Lu Y.P. et al. (2008) Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice. Cancer Res, 68:2523-9.
Heffernan T.P. et al. (2009) ATR-Chk1 pathway inhibition promotes apoptosis after UV treatment in primary human keratinocytes: potential basis for the UV protective effects of caffeine. J Invest Dermatol, 129:1805-15.
Weng Yew Y. et al. (2015) Coffee Consumption and Melanoma: A Systematic Review and Meta-Analysis of Observational Studies. Am J Clin Dermatol, published online ahead of print.
Wang J. et al. (2015) Coffee consumption and the risk of cutaneous melanoma: A meta-analysis. Eur J Nutr, published online ahead of print
Liu J. et al. (2016) Higher caffeinated coffee intake is associated with reduced malignant melanoma risk: A meta-analysis study. PLoS One, published online ahead of print
Tang N. et al. (2010) Coffee consumption and risk of lung cancer: a meta-analysis. Lung Cancer, 67:17-22.
Xie Y. et al. (2015) Coffee consumption and the risk of lung cancer: an updated meta-analysis of epidemiological studies. European Journal of Clinical Nutrition, published online ahead of print.
Holick C.N. et al. (2010) Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies. Cancer Epidemiol Biomarkers Prev, 19:39-47.
Michaud D.S. et al. (2010) Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr, 92:1145-50.
Thomopoulos T.P. et al. (2015) Maternal and childhood consumption of coffee, tea and cola beverages in association with childhood leukemia: a meta-analysis. Cancer Epidemiology, 39(6):1047-1059.
Orsi L. et al. (2015) Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy, and childhood acute leukemia: the ESTELLE study. Cancer Causes Control, 26(7):1003-17.
Nilsson L.M. et al. (2010) Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control, 21:1533-44.
Tiedot on suunnattu terveydenhuollon ammattilaisille ja ravitsemusasiantuntijoille.